Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Yoga for Pain and Opioid Dependence (Yoga)

This study has been completed.
Information provided by (Responsible Party):
Yale University Identifier:
First received: April 30, 2012
Last updated: September 23, 2015
Last verified: September 2015
This study is designed to develop an effective adjunctive treatment using yoga for chronic pain and opioid dependence.

Condition Intervention Phase
Chronic Pain
Opioid Addiction
Other: Yoga
Behavioral: Educational Counseling
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Yoga for Pain and Opioid Dependence

Resource links provided by NLM:

Further study details as provided by Yale University:

Primary Outcome Measures:
  • Pain reduction [ Time Frame: 8 weeks ]
    Pain reduction will be measured by patient self-report using standard pain rating scales.

  • Reduce illicit opioid use [ Time Frame: 8 weeks ]
    Reduced illicit opioid use will be measured by patient self-report and urinalysis testing.

Enrollment: 8
Study Start Date: April 2012
Study Completion Date: November 2014
Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Yoga
Gentle yoga for chronic pain and opioid dependence
Other: Yoga
Two yoga sessions per week for 8 weeks (one yoga session is instructional, the other is a practice session.
Active Comparator: Educational Counseling
Educational counseling is a didactic, lecture-discussion format to supplement the information and advice provided in opioid agonist maintenance treatment.
Behavioral: Educational Counseling
One didactic session per week of approximately 50 minutes that provides information about chronic pain and substance abuse disorders.

Detailed Description:

This study aims to develop an adjunctive novel treatment intervention using yoga in opioid agonist maintained patients to effectively treat the co-occurring disorders of non-malignant chronic pain and opioid dependence (POD).

Specific Aims:

1) To conduct a pre-pilot phase with 8 patients with POD receiving opioid agonist maintenance treatment.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 years of age or older
  • Prescription opioid addiction or heroin addiction
  • Moderate to severe chronic pain,
  • Understands English

Exclusion Criteria:

  • Current suicide or homicide risk
  • Life threatening or unstable medical condition
  • Medical or psychiatric condition that is judged to be of clinical concern by the PI or admitting clinician
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01590251

United States, Connecticut
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
Principal Investigator: Declan T Barry, Ph.D. Yale University
  More Information

Responsible Party: Yale University Identifier: NCT01590251     History of Changes
Other Study ID Numbers: 1111009292
Study First Received: April 30, 2012
Last Updated: September 23, 2015

Keywords provided by Yale University:

Additional relevant MeSH terms:
Chronic Pain
Behavior, Addictive
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Compulsive Behavior
Impulsive Behavior
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents processed this record on April 26, 2017